DNMT3A and periodontitis: CHIP due to DNMT3A mutations was significantly associated with a diagnosis of severe periodontitis (stage IV vs. stages I–III), as well as quantitative measures of “clinical attachment loss” and “gingival inflammation” (Table 1).